Inhibiting NNMT has been proposed as a therapeutic strategy for metabolic disease
Therapeutic Prospects BPC-157 is more stable than endogenous BPC and exhibits therapeutic properties without the need for a carrier agent
Diabetologia 66 (7), 13061321
In metabolic care, complexity is a cost
In these models, the promoter of the gene p16INK4A, a protein involved in cell cycle regulation, was used to control cell cycle transcription, inducing the death of senescent cells by using small molecules
Furthermore, glutathionylated residue C151 of roGFP2 reacted three to four times faster than glutathionylated residue C208, which is again the opposed reactivity as observed for the oxidation kinetics of both monothiol roGFP2 variants (Table 1)